[Urothelial carcinoma of the bladder following cyclophosphamide therapy].
A report is given on a 73-year-old patient in whom a urothelial carcinoma of the urinary bladder developed 11 years after a cyclophosphamide therapy. Taking the international literature into account, possible developmental mechanisms are discussed. Patients who have undergone cyclophosphamide therapy should be subject to constant urological observation as a high-risk group.
D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D002295:Carcinoma, Transitional Cell / Q000139:chemically induced* / Q000601:surgery; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced* / Q000601:surgery
D003520:Cyclophosphamide
Urothelkarzinom der Harnblase nach Cyclophosphamidtherapie.